RCKT

NASDAQStock$3.48-0.04 (-1.28%)
Mkt Cap 379.2MP/E Div Yield Beta 0.57Vol 1.4M
52W$2.33
$8.01

ETFs That Hold RCKT (Rocket Pharmaceuticals, Inc.)

1M

+0.72%

3M

-4.79%

6M

-8.07%

YTD

+0.43%

1Y

-51.47%

3Y

-80.61%

5Y

-92.47%

ETFs That Hold RCKT

Rocket Pharmaceuticals, Inc. is held by 45 ETFs. The largest position by market value is in JCPB (JPMorgan Core Plus Bond ETF).

ETFFund NameWeight
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
AVSUAvantis Responsible U.S. Equity ETF0.00%

Excludes leveraged and inverse ETFs.

PreviousPage 3 of 3

Frequently Asked Questions

How many ETFs hold RCKT?
Rocket Pharmaceuticals, Inc. (RCKT) is held by 45 ETFs (excluding leveraged and inverse funds). The largest position by market value is in JCPB (JPMorgan Core Plus Bond ETF).
What is the largest ETF that holds RCKT?
By fund size, JCPB (JPMorgan Core Plus Bond ETF) with $11.29B in AUM holds 0.15% of its portfolio in RCKT, representing $16.8M in market value.
What percentage of BBC is RCKT?
RCKT makes up 0.81% of BBC (Virtus Biotech Clinical Trials ETF), making it one of the largest positions in that fund.
Is RCKT in the S&P 500?
RCKT is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.